LIVE MARKETS-Heebie-jeebies ahead of PMI data, Brexit, Jackson Hole summit

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Thyagaraju Adinarayan. Reach him on Messenger to share your thoughts on market moves: thyagaraju.adinarayan.thomsonreuters.com@reuters.net

HEEBIE-JEEBIES AHEAD OF PMI DATA, BREXIT, JACKSON HOLE SUMMIT (0643 GMT)

Stock futures indicate a weak open in Europe as anxious investors avoid risky bets ahead of UK PM Boris Johnson's meeting with France's Macron today on Brexit, August PMI data from key euro-zone economies and the Jackson Hole summit on Friday.

Eurostoxx futures are down 0.2% and the CAC and DAX futures are down 0.3%. A pullback was expected after a pretty decent performance across the board yesterday.

German PMI data is due later in the morning, which will indicate if the economy has shown any improvement after contraction last quarter. Later in the day, we'll have updates from Rome on the next steps after Conte's resignation and from Paris on Johnson-Macron Brexit meeting.

In corporate news, NMC Health shares are seen rising 5%-10% after a Reuters report that two investor groups, one of them backed by China's Fosun, are making a bid for a stake in the company.

Osram shares are rising 2% in premarket trade after the German lighting maker cleared the way for AMS to launch its takeover bid. AMS shares are however expected to fall 1% at open.

In earnings, Nordic companies Elekta and GN Store are seen rising 3%-4% after their estimate-beating results and Dutch payments services provider Adyen is seen jumping 5% after solid first-half results.

CRH seen up 2% by traders after the Irish building materials supplier reported "strong numbers across the board" and announced a further 350 million euro share buyback.

Sunrise Communications in focus after the Swiss telco escalated its defence of its planned takeover of Liberty Global's Swiss unit UPC, blasting a shareholder that is fighting the deal.

British drugmaker GlaxoSmithKline shares could get a boost after its new HIV two-drug injection meets main goal in late-stage study.

Key headlines:

Swiss telecom Sunrise touts UPC deal, blasts shareholder as "self-serving"

Deutsche Bank tightens worldwide procedures on new hires - memo

Two groups, one backed by China's Fosun, bid for NMC Health stake-sources

AMS clear to make takeover bid for Osram in potential bidding war

Miner Antofagasta first-half profit jumps 44%

GSK new HIV two-drug injection meets main goal in late-stage study

(Thyagaraju Adinarayan)

*****

EUROPE SEEN TAKING A BREATHER AHEAD OF PMI (0535 GMT)

European stocks are heading for a subdued open as Fed minutes showed policymakers were deeply divided over whether to cut interest rates and ahead of the key PMI data from France and Germany.

"Judging by the reaction in bond markets, and the shorter end in particular, the prospect of a 50bp cut next month is much less of a probability, than it was 24 hours ago," CMC Markets analyst Michael Hewson says.

In Europe, the German PMI data due later today will help investors read into the health of the euro-zone's largest economy, which contracted in the second quarter. Meanwhile in Rome, President Sergio Mattarella is likely to decide today if Italy will go for a snap election.

Here's an explainer on what comes next in Italy:

Financial spreadbetters IG expect London's FTSE to open 29 points lower at 7,175, Frankfurt's DAX to open 36 points lower at 11,767, and Paris' CAC to open 15 points lower at 5,420.

(Thyagaraju Adinarayan)

***** (Reporting by Danilo Masoni, Josephine Mason and Thyagaraju Adinarayan)